Medicared For All Logo

Melvin Palalay in Honolulu, Hawaii

Home Hawaii Honolulu

Melvin Palalay has Hematology/oncology as his primary medical specialty. Their primary office is: 1329 Lusitana St in Honolulu, Hawaii.

They're a part of the: Hawaii Cancer Care Inc medical group which has around 4 members. You can call their office at 808-6115 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Creighton University School Of Medicine and graduated in 1991 (around 33 years of experience). They are listed as doing telehealth appointments.


Melvin P Palalay Office Phone and Directions

Melvin Palalay
Hawaii Cancer Care Inc
1329 Lusitana St
Honolulu, Hawaii 96813
808-6115


Patient Ratings
Please rate your experience with Melvin Palalay below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 808-6115


Enter a starting address:


Healthcare Info for Melvin Palalay

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Creighton University School Of Medicine
Graduation Year: 1991
The Primary Medical Specialty for Melvin Palalay is listed as: Hematology/oncology
Approximate Years of Experience: 33
PAC (PECOS ID)#: 0749362739
NPI #: 1508833971
NPI Created On: 03/03/2006
NPI Last Updated Listed as: 07/18/2019
Primary Taxonomy Code: 207RH0003X
License Number:
MD8905
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Hawaii Medical Service Association
  • Medicare

Languages spoken by staff include: ILOCANO.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Blood test, basic group of blood chemicals
  3. Liver function blood test panel
  4. Carcinoembryonic antigen (cea) protein level
  5. Ferritin (blood protein) level
  6. Lactate dehydrogenase (enzyme) level
  7. Thyroxine (thyroid chemical) measurement
  8. Blood test, thyroid stimulating hormone (tsh)
  9. Uric acid level, blood
  10. Complete blood cell count (red cells, white blood cell, platelets), automated test
  11. Hydration infusion into a vein 31 minutes to 1 hour
  12. Hydration infusion into a vein
  13. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  14. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  15. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  16. Infusion of chemotherapy into a vein up to 1 hour
  17. Infusion of chemotherapy into a vein
  18. New patient office or other outpatient visit, typically 60 minutes
  19. Established patient office or other outpatient visit, typically 15 minutes
  20. Established patient office or other outpatient, visit typically 25 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788329275

Being Disputed:: No

Product Related: No


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788329277

Being Disputed:: No

Product Related: No


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788329279

Being Disputed:: No

Product Related: No


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788329281

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788329283

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788329285

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788329287

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 797181849

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: KRYSTEXXA

Name of Drug #1: KRYSTEXXA

Open Associated Drug #1: 75987-080-10


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013715

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013717

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Hematology/oncology Professionals in Honolulu

3288 Moanalua Rd
Honolulu, HI
Hawaii Permanente Medical Group Inc

3288 Moanalua Rd
Honolulu, HI
Hawaii Permanente Medical Group Inc

3288 Moanalua Rd
Honolulu, HI
Hawaii Permanente Medical Group Inc

226 N Kuakini St
Honolulu, HI
Rehabilitation Hospital Of The Pacific

3288 Moanalua Rd
Honolulu, HI
Hawaii Permanente Medical Group Inc

3288 Moanalua Rd
Honolulu, HI
Hawaii Permanente Medical Group Inc

Providers in Hawaii Cancer Care Inc

1.Jon Fukumoto Md

1329 Lusitana St
Honolulu Hi 96813-2435
Hawaii Cancer Care Inc
Hematology

2.Melvin Palalay

1329 Lusitana St
Honolulu Hi 96813-2435
Hawaii Cancer Care Inc
Hematology/oncology

3.David Tamura

1329 Lusitana St
Honolulu Hi 96813-2435
Hawaii Cancer Care Inc
Hematology/oncology

4.Arnold Yee Md

1329 Lusitana St
Honolulu Hi 96813-2435
Hawaii Cancer Care Inc
Medical Oncology

View all 4 members of Hawaii Cancer Care Inc medical group